Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques
- PMID: 7507326
- DOI: 10.1016/0021-9150(93)90259-w
Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques
Abstract
The key event in the formation of stenosing atherosclerotic lesions is widely thought to be smooth muscle cell proliferation, but the factors primarily responsible for initiating this remain uncertain. Previously we have shown that aqueous extracts of proliferative types of human atherosclerotic plaque stimulate cell proliferation in the chick chorioallantoic membrane (CAM). This has been attributed largely to the fibrin degradation products in the extracts, components removeable by affinity chromatography. We now demonstrate that the fibrinogen content of the extract, removeable by clotting out with thrombin, also makes a contribution to the activity by forming fibrin on the surface of the CAM. Affinity chromatography experiments using anti fragment D and E antisera indicate that activity resides in the E-containing fibrin fragments, consistent with previous work with FDP prepared in vitro.
Similar articles
-
Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):489-93. Blood Coagul Fibrinolysis. 1990. PMID: 1723306
-
Factors relevant to stimulatory activity of fibrin degradation products in vivo.Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):517-20. doi: 10.1097/00001721-199010000-00029. Blood Coagul Fibrinolysis. 1990. PMID: 1723307
-
Fibrin degradation and angiogenesis: quantitative analysis of the angiogenic response in the chick chorioallantoic membrane.J Pathol. 1985 Jan;145(1):27-37. doi: 10.1002/path.1711450103. J Pathol. 1985. PMID: 2578560
-
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.Int J Dev Biol. 1996 Dec;40(6):1189-97. Int J Dev Biol. 1996. PMID: 9032025 Review.
-
Thrombosis in atherogenesis.Crit Rev Oncol Hematol. 1989;9(4):305-18. doi: 10.1016/s1040-8428(89)80016-2. Crit Rev Oncol Hematol. 1989. PMID: 2688680 Review.
Cited by
-
Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12591-5. doi: 10.1073/pnas.95.21.12591. Proc Natl Acad Sci U S A. 1998. PMID: 9770530 Free PMC article.
-
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10335-40. doi: 10.1073/pnas.94.19.10335. Proc Natl Acad Sci U S A. 1997. PMID: 9294211 Free PMC article.
-
Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.J Clin Invest. 1998 Mar 1;101(5):1184-94. doi: 10.1172/JCI1461. J Clin Invest. 1998. PMID: 9486990 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources